The Influence of Pharmaceutical Compounds on Male Fertility*
- 1 September 1976
- journal article
- review article
- Published by Hindawi Limited in Andrologia
- Vol. 8 (3) , 203-235
- https://doi.org/10.1111/j.1439-0272.1976.tb02137.x
Abstract
1. Steroid hormones can affect spermatogenesis and thereby fertility directly and/or indirectly. All antigonadotropically active steroids inhibit spermatogenesis via inhibition of gonadotropin secretion, mainly that of H. Androgens and steroids occurring in the biosynthetic chain of testosterone synthesis have a direct promoting effect on spermatogenesis if applied in high doses. It has not been possible as yet to make clinical use of this positive effect since it is obviously not possible to achieve the necessary intratesticular androgen concentrations. 2. As concerns the different androgens and the steroids in the androgen biosynthetic chain, and also all synthetic anabolics, there is no parallelism between the direct spermatogenic activity, the androgenic activity and the antigonadotropic activity. 3. Estrogens and synthetic gestagens do not inhibit spermatogenesis directly at the testicular level. All effects of estrogens can be abolished experimentally by adequate substitution with gonadotropins or androgens, or a combination of androgens and gonadotropins. 4. Only those antiandrogens inhibit spermatogenesis with additional antigonadotropic properties (e.g. cyproterone acetate). Pure antiandrogens, like flutamide or cyproterone, have a slight and transient influence on spermatogenesis at the most. If at all, they merely cause transient subfertility. 5. Beside steroids and several centrally active pharmaceutics (e.g. psychotropic drugs and several antihypertensive compounds), only siloxanes and methallibur seem to affect spermatogenesis via inhibition of gonadotropin secretion. Other antispermatogenic agents act by inhibition of mitosis (Colchicine, alkylating agents) or presumably via damage of the Sertoli cells. 6. Based on present knowledge, contraception in men could be principally managed by administration of a) androgens alone, b) gestagen/androgen combinations, c) estrogen/androgen combinations, d) certain antiandrogens. 7. The difficulties of contraception in men by steroid hormones or steroid hormone combinations have been pointed out. As regards the usefulness of antiandrogens for contraception, no definite conclusions can be drawn at the moment. All non-steroidal inhibitors of spermatogenesis which have been found up to the present are not suitable because of toxic effects.Keywords
This publication has 81 references indexed in Scilit:
- MitteilungJuristische Rundschau, 1975
- 10D 2. Steroids and the male reproductive system—II 362. Sertoli cell production of testicular androgen binding protein (ABP)Journal of Steroid Biochemistry, 1974
- Evidence for a Specific Seminiferous Tubular Factor Affecting Follicle-Stimulating Hormone Secretion in ManJournal of Clinical Investigation, 1972
- EFFECTS OF ALKYLATING CHEMICALS ON REPRODUCTIVE CELLSAnnals of the New York Academy of Sciences, 1969
- über das Verhalten der Hoden und Hypophysen A-avitaminotischer Ratten und ihre Beeinflu\barkeit durch androgenen WirkstoffVirchows Archiv, 1947
- über die Wirkung verschiedener Gaben von Testosteronpropionat auf den infantilen RattenhodenVirchows Archiv, 1947
- Effect of testosterone propionate on spermatogenesis in hypophysectomized rats following the injection of gonadotropinsThe Anatomical Record, 1942
- Wirkung des Testikelhormonpräparates Erugon auf den Juvenilen RattenhodenKlinische Wochenschrift, 1939
- Die Überlegenheit des Weiblichen Hormons in Seiner Wirkung auf die Männliche und Weibliche Kastraten-Hypophyse Gegenüber Männlichen HormonenKlinische Wochenschrift, 1936
- Die Hormonal-Nervöse Regulierung der Funktion des HypophysenvorderlappensKlinische Wochenschrift, 1932